Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.

Foliaki ST, Lewis V, Finkelstein DI, Lawson V, Coleman HA, Senesi M, Islam AMT, Chen F, Sarros S, Roberts B, Adlard PA, Collins SJ.

PLoS Pathog. 2018 Aug 8;14(8):e1007214. doi: 10.1371/journal.ppat.1007214. eCollection 2018 Aug.

2.

Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases.

Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, Calero M, Collins SJ, Geschwind MD, Sánchez-Valle R, Zerr I, Llorens F.

Mol Neurobiol. 2018 Jul 30. doi: 10.1007/s12035-018-1251-1. [Epub ahead of print]

PMID:
30062673
3.

Prion protein cleavage fragments regulate adult neural stem cell quiescence through redox modulation of mitochondrial fission and SOD2 expression.

Collins SJ, Tumpach C, Groveman BR, Drew SC, Haigh CL.

Cell Mol Life Sci. 2018 Sep;75(17):3231-3249. doi: 10.1007/s00018-018-2790-3. Epub 2018 Mar 24.

4.

The Keepers: The stunning illumination of a cover up of child sexual abuse and institutional betrayal.

Brand BL, Collins SJ, McEwen LE.

J Trauma Dissociation. 2018 Mar 20:1-5. doi: 10.1080/15299732.2018.1452526. [Epub ahead of print] No abstract available.

PMID:
29558282
5.

CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics.

Li QX, Varghese S, Sarros S, Stehmann C, Doecke JD, Fowler CJ, Masters CL, Collins SJ.

J Clin Neurosci. 2018 Apr;50:292-293. doi: 10.1016/j.jocn.2018.01.064.

PMID:
29422367
6.

Acute Neurotoxicity Models of Prion Disease.

T Islam AM, Adlard PA, Finkelstein DI, Lewis V, Biggi S, Biasini E, Collins SJ.

ACS Chem Neurosci. 2018 Mar 21;9(3):431-445. doi: 10.1021/acschemneuro.7b00517. Epub 2018 Feb 14.

PMID:
29393619
7.

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P.

Acta Neuropathol Commun. 2018 Jan 8;6(1):5. doi: 10.1186/s40478-017-0503-z.

8.

Molecular Subtyping of PrPres in Human Sporadic CJD Brain Tissue.

Klug GM, Lewis V, Collins SJ.

Methods Mol Biol. 2017;1658:347-354. doi: 10.1007/978-1-4939-7244-9_23.

PMID:
28861800
9.

Prion Diseases.

Whitechurch BC, Welton JM, Collins SJ, Lawson VA.

Adv Neurobiol. 2017;15:335-364. doi: 10.1007/978-3-319-57193-5_13.

PMID:
28674988
10.

In vivo prion models and the disconnection between transmissibility and neurotoxicity.

Senesi M, Lewis V, Kim JH, Adlard PA, Finkelstein DI, Collins SJ.

Ageing Res Rev. 2017 Jul;36:156-164. doi: 10.1016/j.arr.2017.03.007. Epub 2017 Apr 24. Review.

PMID:
28450269
11.

Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015.

Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E368-E376.

PMID:
28278413
12.

Oxidation of Iron under Physiologically Relevant Conditions in Biological Fluids from Healthy and Alzheimer's Disease Subjects.

Lam LQ, Wong BX, Frugier T, Li QX, Collins SJ, Bush AI, Crack PJ, Duce JA.

ACS Chem Neurosci. 2017 Apr 19;8(4):731-736. doi: 10.1021/acschemneuro.6b00411. Epub 2017 Jan 3.

13.

Simplified Murine 3D Neuronal Cultures for Investigating Neuronal Activity and Neurodegeneration.

Collins SJ, Haigh CL.

Cell Biochem Biophys. 2017 Mar;75(1):3-13. doi: 10.1007/s12013-016-0768-z. Epub 2016 Oct 28.

PMID:
27796787
14.

Creutzfeldt-Jakob disease surveillance in Australia: update to December 2014.

Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean C, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E207-15.

15.

A 2-Substituted 8-Hydroxyquinoline Stimulates Neural Stem Cell Proliferation by Modulating ROS Signalling.

Haigh CL, Tumpach C, Collins SJ, Drew SC.

Cell Biochem Biophys. 2016 Sep;74(3):297-306. doi: 10.1007/s12013-016-0747-4. Epub 2016 Jun 21.

PMID:
27329646
16.

Endoproteolytic cleavage as a molecular switch regulating and diversifying prion protein function.

Haigh CL, Collins SJ.

Neural Regen Res. 2016 Feb;11(2):238-9. doi: 10.4103/1673-5374.177726. No abstract available.

17.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

18.

Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Lewis V, Johanssen VA, Crouch PJ, Klug GM, Hooper NM, Collins SJ.

Cell Mol Life Sci. 2016 Feb;73(3):667-83. doi: 10.1007/s00018-015-2022-z. Epub 2015 Aug 23.

PMID:
26298290
19.

The Prion Protein N1 and N2 Cleavage Fragments Bind to Phosphatidylserine and Phosphatidic Acid; Relevance to Stress-Protection Responses.

Haigh CL, Tumpach C, Drew SC, Collins SJ.

PLoS One. 2015 Aug 7;10(8):e0134680. doi: 10.1371/journal.pone.0134680. eCollection 2015.

20.

A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM.

PLoS One. 2015 Apr 28;10(4):e0123654. doi: 10.1371/journal.pone.0123654. eCollection 2014.

21.

The prion protein regulates beta-amyloid-mediated self-renewal of neural stem cells in vitro.

Collins SJ, Tumpach C, Li QX, Lewis V, Ryan TM, Roberts B, Drew SC, Lawson VA, Haigh CL.

Stem Cell Res Ther. 2015 Apr 11;6:60. doi: 10.1186/s13287-015-0067-4.

22.

Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.

Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA.

Glycobiology. 2015 Jul;25(7):745-55. doi: 10.1093/glycob/cwv014. Epub 2015 Feb 20.

PMID:
25701659
23.

Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013.

Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E348-55.

24.

Neutron reflectometry studies define prion protein N-terminal peptide membrane binding.

Le Brun AP, Haigh CL, Drew SC, James M, Boland MP, Collins SJ.

Biophys J. 2014 Nov 18;107(10):2313-24. doi: 10.1016/j.bpj.2014.09.027.

25.

MEK1 transduces the prion protein N2 fragment antioxidant effects.

Haigh CL, McGlade AR, Collins SJ.

Cell Mol Life Sci. 2015 Apr;72(8):1613-29. doi: 10.1007/s00018-014-1777-y. Epub 2014 Nov 13.

PMID:
25391659
26.

Pratylenchus quasitereoides n. sp. from cereals in Western Australia.

Hodda M, Collins SJ, Vanstone VA, Hartley D, Wanjura W, Kehoe M.

Zootaxa. 2014 Sep 23;3866(2):277-88. doi: 10.11646/zootaxa.3866.2.6.

PMID:
25283659
27.

Ascertainment bias causes false signal of anticipation in genetic prion disease.

Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD.

Am J Hum Genet. 2014 Oct 2;95(4):371-82. doi: 10.1016/j.ajhg.2014.09.003.

28.

Effectiveness of the surgical safety checklist in correcting errors: a literature review applying Reason's Swiss cheese model.

Collins SJ, Newhouse R, Porter J, Talsma A.

AORN J. 2014 Jul;100(1):65-79.e5. doi: 10.1016/j.aorn.2013.07.024. Review.

PMID:
24973186
29.

Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.

Chin J, Marotta R, Chiotis M, Allan EH, Collins SJ.

Mitochondrion. 2014 Jul;17:34-41. doi: 10.1016/j.mito.2014.05.005. Epub 2014 May 17.

PMID:
24846800
30.

C-terminal peptides modelling constitutive PrPC processing demonstrate ameliorated toxicity predisposition consequent to α-cleavage.

Johanssen VA, Johanssen T, Masters CL, Hill AF, Barnham KJ, Collins SJ.

Biochem J. 2014 Apr 1;459(1):103-15. doi: 10.1042/BJ20131378.

PMID:
24438129
31.

Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Brazier MW, Wedd AG, Collins SJ.

Antioxidants (Basel). 2014 Apr 21;3(2):288-308. doi: 10.3390/antiox3020288. Review.

32.

Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012.

Klug GM, Boyd A, Zhao T, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2013 Jun 30;37(2):E115-20.

33.

Updated Creutzfeldt-Jakob disease infection control guidelines: sifting facts from fiction.

Collins SJ, Athan E, Koehler AP.

Med J Aust. 2013 Oct 21;199(8):535-6. No abstract available.

PMID:
24138377
34.

Intensity of human prion disease surveillance predicts observed disease incidence.

Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, Matěj R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, Brandel JP, Alperovitch A, Budka H, Kovacs GG, Jansen GH, Coulthard M, Collins SJ.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi: 10.1136/jnnp-2012-304820. Epub 2013 Aug 21.

PMID:
23965290
35.

Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G).

Simpson M, Johanssen V, Boyd A, Klug G, Masters CL, Li QX, Pamphlett R, McLean C, Lewis V, Collins SJ.

JAMA Neurol. 2013 Sep 1;70(9):1180-5. doi: 10.1001/jamaneurol.2013.165.

PMID:
23857164
36.

Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.

Brazier MW, Mot AI, White AR, Collins SJ.

Ther Deliv. 2013 May;4(5):615-28. doi: 10.4155/tde.13.30. Review. Erratum in: Ther Deliv. 2013 Jun;4(6):762.

PMID:
23647278
37.

Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection.

Sinclair L, Lewis V, Collins SJ, Haigh CL.

Dis Model Mech. 2013 Jul;6(4):952-63. doi: 10.1242/dmm.010678. Epub 2013 Apr 4.

38.

Updated Creutzfeldt-Jakob disease infection control guidelines: sifting facts from fiction.

Koehler AP, Athan E, Collins SJ.

Med J Aust. 2013 Mar 18;198(5):245-6. No abstract available.

PMID:
23496386
39.

Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2011.

Klug GM, Boyd A, McGlade A, Stehmann C, Simpson M, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2012 Jun 30;36(2):E174-9.

40.

The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA.

J Biol Chem. 2012 Oct 19;287(43):36465-72. doi: 10.1074/jbc.M112.368803. Epub 2012 Aug 28.

41.

Preschoolers' sensitivity to speaker action constraints to infer referential intent.

Collins SJ, Graham SA, Chambers CG.

J Exp Child Psychol. 2012 Aug;112(4):389-402. doi: 10.1016/j.jecp.2012.03.008. Epub 2012 May 29.

PMID:
22651891
42.

Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.

Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ.

Mol Neurodegener. 2012 Apr 26;7:18. doi: 10.1186/1750-1326-7-18.

43.

Loss of maternal CTCF is associated with peri-implantation lethality of Ctcf null embryos.

Moore JM, Rabaia NA, Smith LE, Fagerlie S, Gurley K, Loukinov D, Disteche CM, Collins SJ, Kemp CJ, Lobanenkov VV, Filippova GN.

PLoS One. 2012;7(4):e34915. doi: 10.1371/journal.pone.0034915. Epub 2012 Apr 20.

44.

Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.

Lewis V, Whitehouse IJ, Baybutt H, Manson JC, Collins SJ, Hooper NM.

PLoS One. 2012;7(2):e31754. doi: 10.1371/journal.pone.0031754. Epub 2012 Feb 21.

45.

Generating recombinant C-terminal prion protein fragments of exact native sequence.

Johanssen VA, Barnham KJ, Masters CL, Hill AF, Collins SJ.

Neurochem Int. 2012 Feb;60(3):318-26. doi: 10.1016/j.neuint.2011.12.006. Epub 2011 Dec 17.

PMID:
22197912
46.

Mannose receptor 2 attenuates renal fibrosis.

López-Guisa JM, Cai X, Collins SJ, Yamaguchi I, Okamura DM, Bugge TH, Isacke CM, Emson CL, Turner SM, Shankland SJ, Eddy AA.

J Am Soc Nephrol. 2012 Feb;23(2):236-51. doi: 10.1681/ASN.2011030310. Epub 2011 Nov 17.

47.

Metal attenuating therapies in neurodegenerative disease.

Mot AI, Wedd AG, Sinclair L, Brown DR, Collins SJ, Brazier MW.

Expert Rev Neurother. 2011 Dec;11(12):1717-45. doi: 10.1586/ern.11.170. Review.

PMID:
22091597
48.

Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2010.

Klug GM, Boyd A, McGlade A, Stehmann C, Masters CL, Collins SJ.

Commun Dis Intell Q Rep. 2011 Jun;35(2):149-53.

49.

GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells.

Si J, Mueller L, Collins SJ.

Leukemia. 2011 Dec;25(12):1914-8. doi: 10.1038/leu.2011.171. Epub 2011 Jul 26. No abstract available.

PMID:
21788949
50.

Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.

Haigh CL, McGlade AR, Lewis V, Masters CL, Lawson VA, Collins SJ.

Free Radic Biol Med. 2011 Aug 1;51(3):594-608. doi: 10.1016/j.freeradbiomed.2011.03.035. Epub 2011 Apr 3.

PMID:
21466851

Supplemental Content

Loading ...
Support Center